CO2 lidar system for atmospheric studies

A lidar facility using a TEA CO2 laser source is being developed at the ENEA Laboratories for Atmospheric Studies. The different subsystems and the proposed experimental activities are described

Cygnus X-3 in outburst : quenched radio emission, radiation losses and variable local opacity

We present multiwavelength observations of Cygnus X-3 during an extended outburst in 1994 February - March. Intensive radio monitoring at 13.3, 3.6 & 2.0 cm is complemented by observations at (sub)millimetre and infrared wavelengths, which find Cyg X-3 to be unusually bright and variable, and include the first reported detection of the source at 0.45 mm. We report the first confirmation of quenched radio emission prior to radio flaring independent of observations at Green Bank. The observations reveal evidence for wavelength-dependent radiation losses and gradually decreasing opacity in the environment of the radio jet. We find that the radiation losses are likely to be predominantly inverse Compton losses experienced by the radio-emitting electrons in the strong radiation field of a luminous companion to the compact object. We interpret the decreasing opacity during the flare sequence as resulting from a decreasing proportion of thermal electrons entrained in the jet, reflecting a decreasing density in the region of jet formation. We present, drawing in part on the work of other authors, a model based upon mass-transfer rate instability predicting gamma-ray, X-ray, infrared and radio trends during a radio flaring sequence.Comment: LaTeX, 11 pages, 6 figures. Submitted to MNRA

GH therapy in adult GH deficiency: a review of treatment schedules and the evidence for low starting doses.

Recombinant human growth hormone (GH) has been licensed for use in adult patients with GH deficiency (GHD) for over 15 years. Early weight- and surface area-based dosing regimens were effective but resulted in supraphysiological levels of insulin-like growth factor-I (IGF-I) and increased incidence of side effects. Current practice has moved towards individualized regimens, starting with low GH doses and gradually titrating the dose according to the level of serum IGF-I to achieve an optimal dose. Here we present the evidence supporting the dosing recommendations of current guidelines and consider factors affecting dose responsiveness and parameters of treatment response. The published data discussed here lend support for the use of low GH dosing regimens in adult GHD. The range of doses defined as 'low dose' in the studies discussed here (~1-4 mg/week) is in accordance with those recommended in current guidelines and encompasses the dose range recommended by product labels

A critical review on the role of food and nutrition in the energy balance

The mass media has increasingly frequently suggested to the general population that specific foods or nutritional schemes are able to affect both human metabolism and energy expenditure, thus facilitating weight loss. This critical review is aimed at assessing available evidence on the roles of nutrients, food and dietary regimens in energy intake and energy expenditure. We queried the National Library of Medicine, the Cochrane Library, Excerpta Medica dataBASEand the Cumulative Index to Nursing and Allied Health Literature database, and a search strategy was performed by using database-specific subject headings and keywords. We found that available scientific evidence on these topics is scarce, and that the limited number of available studies often have poor methodological quality. Only a few foods show beneficial effects on metabolism and energy expenditure, as the human energy balance is complex and multifactorial. Finally, microbiota may interfere with the intake, use and expenditure of energy in the human body. Conclusive evidence is still lacking, and, at present, it is not possible to identify a food or a diet with a significant impact on human energy expenditure